Phase 2 Hepatitis E Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
Immunogenicity and Safety of Hecolin® in HIV Positive/Negative Adults and in Children
Hepatitis E Virus Infection
International Vaccine Institute1,040 enrolled3 locationsNCT06306196
Recruiting
Phase 2
Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women
Hepatitis E Infection
International Vaccine Institute2,358 enrolled1 locationNCT05808166
Completed
Phase 2
Safety and Immunogenecity Study of an E.Coli Expressed Particulate Recombinant Hepatitis E Vaccine
Hepatitis E
Xiamen YangShengTang Biotechnic Ltd.600 enrolledACTRN12607000368437